SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is trending as investors react to preliminary revenue numbers that fell short of guidance, with some sales pushed to the next quarter due to design upgrades. The community is debating whether this is a buying opportunity or a sign of deeper issues, while also discussing revenue recognition and potential management changes. Despite the dip, some bulls remain optimistic about the company's overall prospects in the AI server market.

D-Wave Quantum, Inc. engages in the development and delivery of quantum computing systems, software, and services. It provides customers with access to the company’s quantum computing systems via the cloud in the form of quantum computing as a service. It offers professional services such as customer assistance in identifying and implementing quantum-computing applications. The company was founded on January 25, 2022 and is headquartered in Palo Alto, CA.

D-Wave Quantum Inc

D-Wave Quantum (QBTS) is trending amid speculation and debate around government investment in quantum computing firms, following a *Wall Street Journal* report. Community discussions revolve around the potential impact of government funding, the company's competitive positioning, and whether the recent price action represents a buying opportunity or a short squeeze. Overall, the stock's movement reflects the high-stakes and speculative nature of the quantum computing sector.

Viking Therapeutics, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of therapies for metabolic and endocrine disorders. The company was founded by Brian Lian and Michael A. Dinerman on September 24, 2012 and is headquartered in San Diego, CA.

Viking Therapeutics Inc

VKTX is trending following positive earnings reports and analysts raising price targets, citing accelerated obesity trials and an upcoming FDA meeting. The community is actively discussing the potential for a short squeeze and speculation around possible M&A activity related to their MASH asset. Bullish sentiment is driven by optimism around their obesity drug pipeline and potential as a strategic target for big pharma.

Quantum Computing, Inc. engages in developing novel algorithms and solutions utilizing quantum and quantum-inspired computing to solve difficult problems in various industries. It leverages its expertise in finance, computing, security, mathematics, and physics to develop commercial applications for the financial, security, and government sectors. The company was founded on July 25, 2001 and is headquartered in Hoboken, NJ.

Quantum Computing Inc

Quantum Computing Inc. is trending amidst speculation and conflicting reports about potential government investment in the quantum computing sector, sparking heated debate among investors. Community discussions revolve around the impact of potential government stakes and the sector's future. QUBT, along with other quantum computing stocks, experiences volatility as investors assess the implications of these developments.

Rigetti Computing, Inc. provides full-stack quantum computing services. It serves global enterprise, government, and research clients through its Rigetti Quantum Cloud Services platform. The company was founded by Chad Rigetti in 2013 and is headquartered in Berkeley, CA.

Rigetti Computing Inc

RGTI is surging amid reports that the Trump administration is considering taking equity stakes in quantum computing firms. The community is buzzing about the potential implications of government involvement in the sector, with some seeing it as a bullish signal, while others express skepticism about the financial impact of a potential deal.

International Business Machines Corp. is an information technology company, which engages in the provision of integrated solutions that leverage information technology and knowledge of business processes. It operates through the following segments: Software, Consulting, Infrastructure, Financing, and Other. The Software segment combines hybrid cloud platform and software solutions to help clients become more data-driven, and to automate, secure, and modernize their environments. The Consulting segment focuses on integrating skills on strategy, experience, technology and operations by domain and industry. The Infrastructure segment offers solutions for hybrid cloud and is the foundation of the hybrid cloud stack. Infrastructure is optimized for infusing AI into mission-critical transactions and tightly integrated with IBM Software including Red Hat for accelerated hybrid cloud benefits. The Financing segment refers to the client and commercial financing, facilitating IBM clients’ acquisition of IT systems, software, and services. The company was founded by Charles Ranlett Flint and Thomas J. Watson Sr. on June 16, 1911 and is headquartered in Armonk, NY.

International Business Machines Corp.

IBM is trending due to mixed reactions to earnings, where a solid Q3 beat was overshadowed by concerns about slowing software growth, particularly from Red Hat. Despite the pullback, some investors see a buying opportunity given IBM's progress in AI, hybrid cloud, and quantum computing, while analysts maintain positive price targets.

Ventyx Biosciences, Inc. engages in developing novel small molecule therapeutics for the treatment of autoimmune diseases. Its clinical stage pipeline includes VTX958, a Phase 1 allosteric TYK2 inhibitor for the treatment of a broad range of autoimmune diseases, VTX002, a Phase 2-ready S1P1 receptor modulator for the treatment of ulcerative colitis, and VTX2735, a Phase 1-ready peripheral inhibitor of the NLRP3 inflammasome, which is a mediator of multiple inflammatory conditions. The company was founded by Raju S. Mohan on November 21, 2018 and is headquartered in San Diego, CA.

Ventyx Biosciences Inc

Ventyx Biosciences ($VTYX) is trending following positive Phase 2 trial results for its obesity and cardiovascular risk drug, leading to significant premarket gains. The community is buzzing about the potential for a buyout by a major pharmaceutical company, particularly Sanofi, given existing collaborations and the drug's promising data. Discussions also revolve around the company's strong cash position and potential dilution concerns.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending amidst discussions around potential government equity stakes in quantum computing firms, sparking mixed reactions within the community. While some investors express optimism about potential funding and fast-tracking of quantum technology, others view it as a pump-and-dump scheme or question the significance of the investment relative to the company's valuation. The conversation also includes comparisons to other companies in the sector and debates about the long-term viability of quantum computing investments.

Brera Holdings Plc engages in the business of football division progression, global football player transfer service, sponsorship services, football school services, and consulting services on football projects. The company was founded on June 30, 2022 and is headquartered in Dublin, Ireland.

Brera Holdings PLC - Ordinary Shares - Class B

SLMT is trending due to its connection to Solana ($SOL), with community members discussing its potential based on Solana's movements and Cathie Wood's ARK Investment stake. Recent news regarding data center selection and M&A strategy exploring opportunities across the Solana value chain are also catalysts. Community chatter highlights a low float and potential for a short squeeze, with some drawing comparisons to other trending stocks.

PG&E Corp. operates as a holding company, which engages in generation, transmission, and distribution of electricity and natural gas to customers. It specializes in energy, utility, power, gas, electricity, solar and sustainability. The company was founded in 1995 and is headquartered in Oakland, CA.

PG&E Corp.

PG&E is trending as the community discusses its potential for price recovery and undervaluation due to embedded risk, especially as fire season concludes. Improving fundamentals, regulated asset upgrades, and potential infrastructure spending are key points, with some anticipating a dividend raise. Analyst upgrades and clean energy policy tailwinds may also be contributing to increased investor attention.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Halper Sadeh LLC Encourages Bioventus Inc. Shareholders to Contact the Firm to Discuss Their Rights

Halper Sadeh LLC, an investor rights law firm, is investigating whether certain officers and directors of Bioventus Inc. (NASDAQ: BVS) breached their fiduciary duties to shareholders. If you...

Bioventus (BVS) Misses Q2 Earnings and Revenue Estimates

Bioventus (BVS) delivered earnings and revenue surprises of -4.55% and -0.26%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Do Options Traders Know Something About Bioventus Stock We Don't?

Bioventus price target raised by $3 at Craig-Hallum, here's why

See the rest of the story here.

thefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...

Q4 2023 Bioventus Inc Earnings Call Transcript

Bioventus Reports Upbeat Earnings, Joins Ranpak, Beachbody And Other Big Stocks Moving Higher On Tuesday

U.S. stocks were higher, with the Dow Jones index surging more than 200 points on Tuesday.
read more...

Bioventus sees 2024 non-GAAP EPS 12c-20c, consensus 33c

Bioventus reports Q4 adjusted EPS 7c, consensus 2c

Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M

Bioventus Non-GAAP EPS of $0.07 beats by $0.05, revenue of $135.42M beats by $11.46M...

Bioventus Announces Fourth Quarter and Full Year 2023 Financial Results

Accelerated fourth quarter sales growth to 7.6%, organic growth* of 14.3%Appointed Rob Claypoole as President and Chief Executive Officer, bringing more than 20 years of leadership experience in the...

Bioventus, Inc. is a medical technology company, which focuses on developing and commercializing and proprietary orthobiologic products for the treatment of patients suffering from an array of musculoskeletal conditions. It operates through the following business segments: Active Healing Therapies-U.S, Active Healing Therapies-International, Surgical and BMP. The Active Healing Therapies-U.S and International offers two types of non-surgical products which are non-invasive exogen system for long bone stimulation for fracture healing and hyaluronic acid, or HA, viscosupplementation therapies for osteoarthritis pain relief. The Surgical segment offers a portfolio of advanced bone graft substitutes. The BMP segment comprises proprietary next-generation bone morphogenetic protein, or BMP. The company was founded on November 23, 2011 and is headquartered in Durham, NC.

Current Price	$7.16
Prev Close	$7.11
Open	$7.13
Dividend Yield	0.00%
50-Day Moving Average	$7.03
Beta	1.36
Avg. Volume	297,650.48
PE Ratio	-960.81

52-Week High	$14.38
52-Week Low	$5.81
Market Capitalization	$475.6M
EPS (Annual)	-$0.5196
Price to Book	2.95
Revenue Per Employee	$616,430.11
Enterprise Value/EBITDA	N/A

BVS
Bioventus Inc - Ordinary Shares - Class A

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest BVS News

BVSBioventus Inc - Ordinary Shares - Class A